BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 11:27:00 AM | Browse: 402 | Download: 379
Publication Name World Journal of Pharmacology
Manuscript ID 4362
Country of Manuscript Source Austria
Received
2013-06-28 10:51
Peer-Review Started
2013-06-28 16:50
To Make the First Decision
2013-08-08 11:11
Return for Revision
2013-08-19 20:14
Revised
2013-08-21 22:14
Second Decision
2013-10-16 11:16
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-10-16 12:08
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-10-25 15:59
Publish the Manuscript Online
2013-12-18 16:32
ISSN 2220-3192 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Pharmacology and Pharmacy
Manuscript type Minireviews
Article Title Statins role in cancer prevention and development-recent meta-analyses
Manuscript Source Invited Manuscript
All Author List Martin Künzl, Christine Wasinger and Martin Hohenegger
Funding Agency and Grant Number
Funding Agency Grant Number
Herzfeldersche Familienstiftung and the Austrian Science foundation P22385
Correspondence To Martin Hohenegger, MD, Associate Professor, Medical University of Vienna, Center for Physiology and Pharmacology, Institute of Pharmacology, Währingerstrasse 13A, A-1090 Vienna, Austria. martin.hohenegger@meduniwien.ac.at
Keywords 3-Hydroxy-3-methylglutaryl-coenzyme A-reductase inhibitors; Low density lipoprotein cholesterol; Cancer; Breast cancer; Apoptosis; Statins
Core Tip The 3-hydroxy-3 methyl CoA (HMG-CoA) reductase inhibitors, the statins are one of the most frequently prescribed drugs in industrialized countries. Statins are well tolerated cholesterol lowering drugs which significantly help to reduce cardiovascular events. Clinical trials and meta-analyzes thereof now accumulate evidence that development of cancer might be reduced in some tissues. In this review the current status of evidence for an anti-cancer effect of statins will be critically evaluated. In particular, colon and prostate cancer are assessed in greater detail.
Publish Date 2013-12-18 16:32
Citation Künzl M, Wasinger C, Hohenegger M. Statins role in cancer prevention and development-recent meta-analyses. World J Pharmacol 2013; 2(4): 100-106
Url http://www.wjgnet.com/2220-3192/full/v2/i4/100.htm
DOI http://dx.doi.org/10.5497/wjp.v2.i4.100
Full Article (PDF) WJP-2-100.pdf
Full Article (Word) WJP-2-100.doc
Manuscript File 4362-Review.doc
Answering Reviewers 4362-Answering reviewers.PDF
Copyright License Agreement 4362-Copyright assignment.PDF
Peer-review Report 4362-Peer reviewer(s).pdf
Scientific Editor Work List 4362-Scientific editor work list.doc